hepatectomy

A Hepatectomy is considered a major surgery done under general anesthesia.

The word "hepatectomy" is a fusion of Latin and Greek.

Partial hepatectomy: Removal of the part of the liver where cancer is found.

Studies on partial hepatectomy, liver regeneration and transplantation are items of this program.

Hepatectomy is the surgical resection of the liver.

Laparoscopic major hepatectomy: an evolution in standard care.

Surgery (total hepatectomy) and liver transplant.

Partial hepatectomy to resect all of the tumor.

Such inhibitors also prevent the increase in calmodulin within the nucleus of liver cells following hepatectomy.

One-year morbidity after donor right hepatectomy.

Seventy per cent hepatectomy was performed as described by Higgins and Anderson under ether anaesthetic.

The well described fall in EGF receptor numbers after partial hepatectomy was confirmed.

Surgery (partial hepatectomy).

Younger patients with metastases from colorectal cancer, confined to one lobe of liver and up to 4 in number, may be treated by partial hepatectomy.

Surgical resection, partial hepatectomy, and embolization of afferent vessels should be considered for severe cases.

When the disease is localized to one hepatic lobe, hepatectomy relieves symptoms and appears to remove the risk of malignancy.

Hepatectomy may also be the procedure of choice to treat intrahepatic gallstones or parasitic cysts of the liver.

Total hepatectomy and liver transplant: Removal of the entire liver and replacement with a healthy donated liver.

For patients with T2 or greater disease, extended resection with partial hepatectomy and portal node dissection may be an option.

Intrahepatic cholangiocarcinomas (those arising from the bile ducts within the liver) are usually treated with partial hepatectomy.

Scatchard analysis (Table II) of binding data (not shown) show a 45% reduction 24 hours following a 70% hepatectomy.

Studies in adults in China suggest that repeated hepatic transarterial chemoembolization before surgery may improve the outcome of subsequent hepatectomy.

In series of carefully selected patients, partial hepatectomy has resulted in a 5-year survival of 30% to 40%, with median survivals approaching 3 years.

The patients received an i.v. infusion of BPA, followed by removal of the liver (hepatectomy).

A substantial body of evidence implicates events at the EGF receptor as the start of hepatocyte proliferation after partial hepatectomy.